ArticleDrug safety2023
Future of ChatGPT in Pharmacovigilance.
Article in Drug safety, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Chatbots for breast cancer education: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024Pooled it
- Large Language Models in Adverse Drug Reaction Detection and Pharmacovigilance: A Systematic Review of Current Applications, Challenges, and Future Directions.Diagnostics (Basel, Switzerland) · 2026Review
- How is AI developing in pharmacovigilance?Therapeutic advances in drug safety · 2026Article
- Performance and Reproducibility of Large Language Models in Named Entity Recognition: Considerations for the Use in Controlled Environments.Drug safety · 2025Article
- Performance of ChatGPT-3.5 and ChatGPT-4 in the Taiwan National Pharmacist Licensing Examination: Comparative Evaluation Study.JMIR medical education · 2025Article
- Can large language models detect drug-drug interactions leading to adverse drug reactions?Therapeutic advances in drug safety · 2025Article
- Evaluating the capability of ChatGPT in predicting drug-drug interactions: Real-world evidence using hospitalized patient data.British journal of clinical pharmacology · 2024Article
- Engine of Innovation in Hospital Pharmacy: Applications and Reflections of ChatGPT.Journal of medical Internet research · 2024Article
- Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts.BMC health services research · 2024Article
- Article
- Causality Assessment of Adverse Drug Reaction Toxic Epidermal Necrolysis With the Aid of ChatGPT: A Case Report.Cureus · 2024Article
- A Systematic Review and Meta-Analysis of Artificial Intelligence Tools in Medicine and Healthcare: Applications, Considerations, Limitations, Motivation and Challenges.Diagnostics (Basel, Switzerland) · 2024Review
- Editorial: Traditional and innovative approaches for signal detection.Frontiers in drug safety and regulation · 2024Article
- Pharmacoepidemiology: An Overview.Journal of clinical medicine · 2023Review
- Leveraging AI chatbots in supporting breast and ovarian cancer patients: A scoping review.Digital healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.